Keywords: fMRI Analysis, Breast
Motivation: Limited clinical studies have explored the potential of Amide Proton Transfer Weighted Imaging (APTWI) in discriminating between benign and malignant breast lesions and molecular subtypes of breast cancer.
Goal(s): This study aims to assess the clinical utility of APTWI and DKI in the evaluation of benign and malignant breast diseases and the determination of molecular subtypes of breast cancer.
Approach: We quantitatively analyzed lesions in breast MRI scans of patients prior to surgery and evaluated the diagnostic value of each quantitative parameter.
Results: APTWI did not exhibit superior diagnostic efficacy compared to DKI and ADC in characterizing the molecular subtypes of breast cancer.
Impact: Our study underscores that APT imaging, as a novel quantitative magnetic resonance technique, does not confer a diagnostic advantage over DKI and ADC in the context of breast disease assessment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords